Published 2 years ago

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

Summary by Ground News

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released a second white paper. The White Paper describes the use of HTG’s Transcriptome Panel (HTP) in early-stage design, selection and characterization of small-molecule candidates.

0 Articles

All

Left

Center

Right

Globe Newswire

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

TUCSON, Ariz., July 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision...

2 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

0 Articles

0 Articles

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

HTG Releases Second Whitepaper for its Transcriptome-Informed Approach to Drug Discovery

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics